"The research is not paid for..."????
Oh, of course not:
"Present at SeeThruEquity's Next Conference
Presenting Company Package - $6,500"
And look what we have here:
"Conference Tomorrow--SeeThruEquity Winter Microcap Investor Conference to be held at Convene Midtown East on February 6 [2014] is open.
Confirmed presenting companies include:
Competitive Technologies, Inc. OTCQB: CTTC Healthcare"
Obviously, a totally "unpaid," unbiased opinion! NOT!!
I think I'll ask the SEC how legitimate is to claim no payment and imply no vested interest when CLEARLY they ARE paid and no doubt want CTTC to come to MORE of their conferences!
Nevertheless, good for a laugh:
"Patients typically undergo 12 treatments over a two week period..." They do??? That appears to be a 20% increase in what MISTER Marineo's protocol states -- then again, since he's disowned CTTC, who cares? Right?
The next sentence is just precious:
"Physicians can lease the Calmare(r) pain therapy device for around $2,000 per month, resulting in a very attractive economic value to their practices."
He kinda leaves out the part about actually finding suck...uhhhh...patients! Not to mention actually getting paid! Then you have to figure, the practitioner is LOSING two grand a month!
Then comes:
"CTI has reported a wide range of reimbursement levels for Calmare(r) therapy device treatments, even within the same geographic locations."
Now, that just had me on the floor rolling around laughing! Yeah, right! "Wide" range -- somewhere between ZERO and...uhhh...uhhhhhh...NOTHING! Yeah, NOTHING! REAL wide "range" there!
As far as "ample room for physicians to make healthy returns using the device," evidently the guy hasn't read CTTC's SEC filings since those "healthy returns" for physicians don't seem to have generated much revenue for CTTC in the 6-7 YEARS that the thing has been available!
Great fun! Thanks for the post!